HIV 1 News and Research

RSS

New app aims to provide vital support to people battling opioid-use disorder

With opioid-overdose deaths reaching an all-time high during the COVID-19 pandemic, a new app developed at UVA Health is helping people struggling with opioids get the care they need.

19 May 2022

Combined COVID-19 vaccination regimen found to induce more potent anti-SARS-CoV-2 antibodies

Researchers assessed the vaccine-induced humoral responses against SARS-CoV-2 post four different vaccination regimens comprising homologous and heterologous vaccine doses.

18 May 2022

Researchers explore COVID-19 vaccination in immunocompromised individuals

A new study discusses the safety and efficacy of the COVID-19 vaccination and potential strategies to optimize protection in patients with impaired immunity.

17 May 2022

Broad-spectrum polymeric antivirals against SARS-CoV-2

In a recent study published in the journal Advanced Science, researchers evaluated the potential and applicability of macromolecular viral inhibitors against respiratory viral pathogens.

17 May 2022

Study explores macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with anti-SARS-CoV-2 activities

Researchers created polystyrene sulfonate with significantly different molar masses, constructed these polymers as an exterior around spherical gold nanoparticles of various sizes to improve multivalency effects, measured antiviral effects of the antivirals on numerous viruses in vitro, and investigated the method of interaction of the leads with SARS-CoV-2 and lentiviral particles.

13 May 2022

UCL takes second position in research excellence across UK institutions

The excellence of research at UCL and its positive real-world impact has improved since 2014, according to the Research Excellence Framework 2021 (REF) assessment results announced today.

12 May 2022

Study estimates effectiveness of 2-dose and 3-dose mRNA vaccination against Omicron

In a recent study posted to the medRxiv* preprint server, researchers estimated the efficacy of two-dose and three-dose regimens of two messenger ribonucleic acid (mRNA) vaccines: Moderna’s mRNA-1273 and Pfizer-BioNTech’s BNT162b2 against coronavirus disease 2019 (COVID-19) caused due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant.

12 May 2022

Clemson researchers discover a promising therapy for people suffering from toxoplasmosis

Many doctors caution their pregnant patients to avoid cat feces; even the family pet's litter box is off-limits. Now, a group of researchers from Clemson University have discovered a promising therapy for those who suffer from toxoplasmosis, a disease caused by the microscopic protozoa Toxoplasma gondii.

11 May 2022

Inexpensive daily diet supplementation in pregnancy can reduce complications at birth, study shows

A six-year study of nearly 100,000 women in Botswana has provided new evidence that relatively inexpensive daily diet supplementation of iron, folic acid and vitamin supplementation in pregnancy can reduce complications at birth.

11 May 2022

UC Davis researchers identify a protein that keeps Kaposi's sarcoma-associated herpesvirus dormant

A team of UC Davis researchers has identified a protein in the cancer cell's nucleus as a critical agent keeping Kaposi's sarcoma-associated herpesvirus (KSHV) dormant and undetected by the body's immune system.

11 May 2022

The 'Big Three' could benefit from the phenomenal strides in vaccine technology

Three historically neglected diseases - the 'Big Three', namely tuberculosis, malaria and HIV/AIDS- could be set to benefit from the phenomenal strides that have occurred in vaccine technology in the 2020s.

11 May 2022

Study investigates antibody-mediated response against different SARS-CoV-2 variants

In a recent study posted to the bioRxiv* preprint server, researchers assessed the impact of coronavirus disease 2019 (COVID-19) on antibody-mediated immunity.

10 May 2022

Cancer mortality in sub-Saharan Africa could reach 1 million by 2030 without rapid interventions

Annual cancer deaths in sub-Saharan Africa (SSA) could reach 1 million by 2030, nearly double the 520,000 deaths from cancer that occurred in 2020.

9 May 2022

New genetic markers could improve early detection of drug-resistant tuberculosis

To many, tuberculosis (TB) may seem like a disease from a bygone era. But it still claims more than one million lives every year.

9 May 2022

Deoxyribonucleic acid nanostructure sensor found to rapidly detect and inhibit SARS-CoV-2

Researchers reported on a three-layer designer deoxyribonucleic acid (DNA) nanostructure (DDN) strategy-based sensor designed by them for rapid and accurate SARS-CoV-2 detection and inhibition.

9 May 2022

Differences in COVID-19 outcomes related to sex

Researchers looked at gender variations in COVID-19 outcomes such as hospitalization, ICU admission, mortality, and heart damage.

9 May 2022

Evaluation of the potential of new and repurposed TB vaccines

A new study evaluated effective vaccination strategies for two TB vaccines, M72/AS01E and BCG.

5 May 2022

NIH awards $11.3 million grant to renew the Einstein-Rockefeller-CUNY Center for AIDS Research

The National Institutes of Health has awarded Albert Einstein College of Medicine a five-year, $11.3 million grant to renew the Einstein-Rockefeller-CUNY Center for AIDS Research and expand its efforts to prevent, treat and cure HIV infection, and thereby reduce the burden of HIV, locally, nationally, and internationally.

3 May 2022

EIS Conference highlights CDC’s disease detectives’ outbreak investigations, innovative analyses on public health

CDC will hold its annual Epidemic Intelligence Service Conference May 2-5, 2022, via a virtual platform that is free and open to the public.

3 May 2022

Mexico City Policy may be associated with higher maternal, child mortality and HIV incidence rates

Restricting US foreign aid for non-governmental organizations (NGOs) that provide information on or access to abortion-related services in developing countries may have harmful effects on maternal and child mortality and HIV incidence rates on the same scale as an ongoing civil conflict.

2 May 2022

HIV 1 News and Research

New app aims to provide vital support to people battling opioid-use disorder

Combined COVID-19 vaccination regimen found to induce more potent anti-SARS-CoV-2 antibodies

Researchers explore COVID-19 vaccination in immunocompromised individuals

Broad-spectrum polymeric antivirals against SARS-CoV-2

Study explores macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with anti-SARS-CoV-2 activities

UCL takes second position in research excellence across UK institutions

Study estimates effectiveness of 2-dose and 3-dose mRNA vaccination against Omicron

Clemson researchers discover a promising therapy for people suffering from toxoplasmosis

Inexpensive daily diet supplementation in pregnancy can reduce complications at birth, study shows

UC Davis researchers identify a protein that keeps Kaposi's sarcoma-associated herpesvirus dormant

The 'Big Three' could benefit from the phenomenal strides in vaccine technology

Study investigates antibody-mediated response against different SARS-CoV-2 variants

Cancer mortality in sub-Saharan Africa could reach 1 million by 2030 without rapid interventions

New genetic markers could improve early detection of drug-resistant tuberculosis

Deoxyribonucleic acid nanostructure sensor found to rapidly detect and inhibit SARS-CoV-2

Differences in COVID-19 outcomes related to sex

Evaluation of the potential of new and repurposed TB vaccines

NIH awards $11.3 million grant to renew the Einstein-Rockefeller-CUNY Center for AIDS Research

EIS Conference highlights CDC’s disease detectives’ outbreak investigations, innovative analyses on public health

Mexico City Policy may be associated with higher maternal, child mortality and HIV incidence rates

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News